
Senate Passes One Big Beautiful Bill Despite One Big Not-So-Beautiful Price Tag
Senate Republicans narrowly passed President Donald Trump's 'One Big Beautiful Bill' with a 51-50 vote after three Republicans—(Sens. Susan Collins (Maine), Rand Paul (Ky.), and Thom Tillis (N.C.)—joined Democrats in voting no. Vice President JD Vance cast the tiebreaker vote.
The tax provisions in the Senate would make permanent a number of the expiring tax cuts contained in Trump's signature 2017 tax legislation— the Tax Cuts and Jobs Act (TCJA). According to the Penn Wharton Budget Model (PWB Model), a nonpartisan, research-based initiative that provides an economic analysis of public policy's fiscal impact, making those cuts permanent would increase the deficit by $4.3 trillion over 10 years. These changes would be partly offset by spending cuts of $1.460 trillion for a total conventional cost of $3.104 trillion.
The PWB Model analysis scored the legislation against a current law baseline. That's also how the Joint Committee on Taxation originally scored the bill.
The baseline impacts how the cost of extending tax cuts is calculated (that's called scoring) and how it impacts the overall budget. As you know from past bills, including the Bush tax cuts, the Tax Cuts and Jobs Act, and the Inflation Reduction Act, it has long been the case that bills are scored based on the cost to move forward based on current law (so, in all of those examples, any provisions that were set to expire are reset to zero while those previously made permanent are ignored).
Senate Republicans had requested that the JCT rescore it using a new approach called a current policy baseline. With a current policy baseline, extending provisions that are set to expire are scored as having zero cost. The Parliamentarian ruled that the new approach breaks the rules—this is consistent with precedent.
With a current law baseline, the cost of the extensions is fully counted. Senate Committees
According to the PWB Model analysis, increases in spending under the Armed Services, Judiciary, and Homeland Security and Governmental Affairs Committees would add $290 billion to the deficit. While other committees proposed net spending cuts or revenue increases, the savings amount to only $1.5 trillion, offsetting less than one-third of the $4.6 trillion increase in deficits from tax cuts and spending increases.
You can see how those costs are expected to play out here:
Penn Wharton Budget Model Analysis, Senate Bill Kelly Phillips Erb
(You can read more about the TCJA extensions as they originally appeared in the House version of the bill here.) Major Spending Cuts
The Senate bill includes changes to health programs, including Medicaid. Notably, it would cut Medicaid spending by imposing work requirements, restricting state-level taxes on healthcare providers that receive federal matching funds, increasing the frequency of eligibility checks, changing Medicaid eligibility requirements based on immigration status, and phasing down state-directed payments to providers to align with Medicare rates. Overall, cuts to Medicaid would reduce the federal deficit by more than $900 billion.
The bill also reduces spending on the Supplemental Nutrition Assistance Program (SNAP, also known as food stamps) by $186 billion over ten years. The cost doesn't just disappear—it shifts the responsibility for payment to the states with a new cost-sharing formula. It would also create additional work documentation requirements, shift administrative costs to states, and make other changes to reduce federal SNAP costs.
The Health, Education, Labor, and Pensions Committee eliminates subsidized and income-driven loan repayment plans, imposes new limits on student borrowing, and tightens the eligibility requirements for Pell Grants. Altogether, it would reduce spending by $350 billion over the budget window. Impact To The Federal Debt
Overall, the PWB Model analysis predicts that the bill would increase debt by 7.6% over 10 years and decrease gross domestic product (GDP) by 0.3% over the same period.
That's different than the impact to the federal deficit.
Here's the quick difference between deficit and debt: The federal deficit is the excess of expenditures over revenue in a fiscal year. In simple terms, if we spend more than we take in, we have a deficit. If we spend exactly what we take in, we achieve a balanced budget. If we take in more than we spend, we have a surplus.
The deficit is recalculated annually based on the shortfall or surplus each month. If there is a deficit, the Treasury borrows money to make up the difference. The Treasury accomplishes this by selling securities like T-bills, notes, and savings bonds.
The federal debt is essentially the total of the deficits. So, if we owe $800 million one year and it's not repaid, and in another year we owe $500 million that is also not repaid, we accumulate a debt of $1.3 billion. Make sense? Since this amount represents borrowed money, we also pay interest on it, causing it to continue growing even if we are not actively adding to it. Next Steps
Now that the bill has passed the Senate, it moves back to the House. Speaker Mike Johnson can only afford to lose three votes—the last iteration in the House passed 215-214. The versions passed in the House and Senate must match exactly for the bill to become law. Forbes What's Comes Next For The One Big Beautiful Bill Act By Kelly Phillips Erb Forbes As The Byrd Bath Continues, Here's A Look At What Will Likely Be Out Of The One Big Beautiful Bill (Updated) By Kelly Phillips Erb Forbes House Passes Trump Tax Bill After Marathon Session, Now It Moves To The Senate By Kelly Phillips Erb Forbes A Guide To The Tax Cuts In (And Out) Of Trump's 'Big, Beautiful Bill' By Kelly Phillips Erb
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Washington Post
34 minutes ago
- Washington Post
Maryland's ‘fight is not over' after Trump's decision to keep FBI in D.C.
After a 15-year effort to entice the FBI to move to the Maryland suburbs, the state's leaders are preparing to fight the Trump administration's decision to keep the agency's headquarters in D.C. with a playbook honed eight years ago, the last time the project was thrown into limbo, according to two people familiar with the strategy who requested anonymity to discuss the plan.
Yahoo
37 minutes ago
- Yahoo
2025 NBA free agency: Deandre Ayton addition slightly improves Los Angeles Lakers' title odds
The Los Angeles Lakers finally have a new center after agreeing to a two-year deal with free agent and former No. 1 overall pick Deandre Ayton, and oddsmakers have bumped up their odds to win next year's NBA championship as a result. The Lakers moved from 16-1 to 14-1 to win the 2025-26 NBA championship at BetMGM, the seventh-best odds of any team and the fourth-best odds for any Western Conference team behind favorite Oklahoma City (+275), Denver (+700) and Houston (+800). Advertisement "They filled an obvious need with a previously unexpected option," Jeff Sherman, vice president of risk at the Westgate Las Vegas SuperBook told Yahoo Sports via text. "We went from 16-1 to 14-1 for perception purposes. We already have — and will continue to have — Lakers liability." The Lakers made the playoffs as the third seed in the West last season after trading for Luka Dončić in the middle of the season, but lost to the Minnesota Timberwolves in the first round in five games. As of Tuesday morning, the Lakers were the second-biggest title liability at BetMGM behind the Dallas Mavericks.
Yahoo
41 minutes ago
- Yahoo
3 Giant Dividend Stocks to Buy to Shield Your Portfolio Now
During periods of market volatility and economic uncertainty, investors often look for refuge in dependable, dividend-paying stocks. These rare giants provide not only consistent income but also long-term stability. Dividend giants are typically well-established companies with strong cash flows, resilient business models, and a long history of rewarding shareholders, which can help safeguard your portfolio. 3 Overlooked Dividend Aristocrats To Buy in 2025 3 Giant Dividend Stocks to Buy to Shield Your Portfolio Now Get exclusive insights with the FREE Barchart Brief newsletter. Subscribe now for quick, incisive midday market analysis you won't find anywhere else. Valued at nearly $328 billion, AbbVie (ABBV) is a U.S.-based biopharmaceutical company focused on treating autoimmune disorders, cancers, neurological conditions, and aesthetic medical needs. Its strong cash flow, innovative research, and diverse portfolio of leading medicines position it as a global leader in both prescription therapeutics and aesthetics. AbbVie has a forward dividend yield of 3.5%, which is higher than the healthcare sector average of 1.58%. While the yield is appealing, a reasonable payout ratio indicates how much of its net income the company distributes as dividends while leaving enough to reinvest in the business. Its forward payout ratio of 46.9% is relatively low, indicating that dividend payments are sustainable and have room to grow. AbbVie is also a Dividend King, having paid and increased dividends for 53 straight years. AbbVie is best known for its blockbuster drug Humira, which treats autoimmune diseases such as rheumatoid arthritis, Crohn's disease, and psoriasis. However, to deal with Humira's patent expiration, the company has expanded its portfolio to include blockbuster drugs such as Skyrizi (for psoriasis and Crohn's) and Rinvoq (for rheumatoid arthritis and ulcerative colitis). In the most recent first quarter, Skyrizi's sales stood at $3.4 billion, up 70.5%, while Rinvoq's were $1.7 billion, up 57.2%. Adjusted earnings increased 6.5% in the quarter. Overall, Wall Street has assigned a 'Moderate Buy' rating to AbbVie stock. Out of 27 analysts covering the stock, 14 have a 'Strong Buy' rating, two suggest a 'Moderate Buy' rating, and 11 recommend a 'Hold' rating. The mean target price for ABBV is $208.88, which is 10% above its current levels. Its high price estimate of $250 implies potential upside of 33% over the next 12 months. AT&T (T) is a major American telecommunications company with a market capitalization of $208 billion. It offers wireless services, internet and broadband services, TV and streaming services, as well as business and enterprise solutions like network connectivity, cybersecurity, and cloud services. AT&T offers an attractive forward dividend yield of 3.85%, which is significantly higher than the communications sector average of 2.6%. Importantly, the company's forward payout ratio has improved to 49.7%, thanks to a simpler business model and strong free cash flow (FCF). In the first quarter, the company generated $3.1 billion in FCF, paying out dividends totaling $1.1 billion. Adjusted earnings per share rose by 6.3% in Q1. Furthermore, it expects to generate more than $16 billion in FCF by 2025, which should support dividend payouts. Overall, Wall Street rates AT&T stock as a "Moderate Buy.' Of the 28 analysts covering the stock, 17 recommend a "Strong Buy,' three recommend a 'Moderate Buy,' seven rate it a "Hold,' and one suggests a 'Strong Sell.' Currently, the stock is trading close to its average analyst target price of $29.21. Its high price target of $34, however, represents upside potential of 17.5% over the next 12 months. Valued at $45 billion, Target (TGT) is a major American retail company. Target is known for its low prices, trendy private-label brands, and excellent in-store and online shopping experiences. It also provides same-day delivery and curbside pickup. Target is part of the elite group of Dividend Aristocrats, a group of S&P 500 Index ($SPX) companies that have increased their dividends for at least 25 consecutive years. Target has raised its dividend annually for over 54 consecutive years as of 2025, also putting it in the even more exclusive Dividend Kings club. It recently increased its dividend by 1.8%. The company pays an attractive dividend yield of 4.4%, which is significantly higher than the consumer staples average of 1.9%. Behind every reliable dividend payer is a strong financial engine. While consumer spending can fluctuate, Target's business model enables it to adapt quickly. During a recession, consumers often migrate from premium retailers to value-oriented stores, giving Target a competitive edge. Target's adjusted earnings for the first quarter increased 11.8% to $2.27 per share. The company's payout ratio is within a sustainable range of 56.8%. This means Target has enough room to continue rewarding shareholders while reinvesting in its operations. Overall, Wall Street rates Target stock as a "Moderate Buy.' Of the 34 analysts covering the stock, eight recommend a "Strong Buy,' three say it is a 'Moderate Buy,' 21 rate it a "Hold,' and two suggest a 'Strong Sell.' Based on its average analyst target price of $110.25, the stock has upside potential of 10.9% from current levels. Plus, its high price target of $175 represents upside potential of 77.4% over the next 12 months. On the date of publication, Sushree Mohanty did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data